October 31, 2023
Late-Breaking Clinical Trial outcomes from The VEINS Conference: CLOUT Registry, VIVID Trial, DEXTERITY-AFP Trial, and Venous Thromboembolism Treatment
October 31, 2023 — Results of four late-breaking clinical trials presented during the The VEINS Conference 2023, taking…
Read More
Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two contemporary mitral transcatheter edge-to-edge repair (TEER) therapies
October 31, 2023
CLASP IID One-year Data Confirm Safety and Efficacy of Edwards Pascal System for Degenerative Mitral Regurgitation
October 31, 2023 — Edwards Lifesciences Corporation announced one-year results from CLASP IID, the first randomized…
Read More
The findings will impact the interventional treatment of High Bleeding Risk patients
October 31, 2023
Positive Results Revealed in Clinical Trial COMPARE 60/80 for High Bleeding Risk Patients
October 31, 2023 — SMT (Sahajanand Medical Technologies), a leading medical device company in India, focused on…
Read More
The findings will impact the interventional treatment of High Bleeding Risk patients
October 31, 2023
Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
October 31, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover,…
Read More
October 30, 2023
Shockwave Medical Debuts Enhanced Catheter at TCT 2023, Announces Clinical Research Validation
October 30, 2023 — Shockwave Medical, Inc., which develops technologies for the treatment of cardiovascular disease,…
Read More
Data from first coronary DCB study in U.S. meet 12-month primary endpoint, demonstrate low adverse event rates with AGENT DCB
October 30, 2023
Boston Scientific AGENT Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial
October 30, 2023 — Boston Scientific Corporation on Friday announced positive 12-month results from the pivotal AGENT…
Read More
Abbott's landmark LIFE-BTK randomized clinical trial met its primary safety and effectiveness endpoints, demonstrating that Esprit BTK offers significant advancements in opening and keeping blocked arteries below-the-knee open compared to the standard of care, balloon angioplasty
October 30, 2023
Late-breaking Data Show Esprit BTK Drug-eluting Resorbable Scaffold Reduces Chronic Limb-threatening Ischemia Progression Compared to the Standard of Care
October 30, 2023 — Abbott announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit BTK…
Read More
Key findings demonstrate patients with aortic stenosis have substantial untreated mortality risk across all levels of aortic stenosis severity, but aortic valve replacement rates remain low even for patients with severe aortic stenosis
October 30, 2023
Philippe Généreux, MD Presents Novel Research on Aortic Stenosis from egnite, Inc.’s Database at TCT23
October 30, 2023 — -egnite, Inc., a leading cardiovascular digital health company, announced today that novel research…
Read More
WATCH TAVR trial presented at the Transcatheter Cardiovascular Therapeutics annual conference
October 26, 2023
iFR and FFR are Equally Safe to Diagnose and Treat Heart Disease According to Largest-ever Analysis of New Real-world, Long-term Data
October 26, 2023 —  Royal Philips, a global leader in health technology, announced the latest results demonstrating the…
Read More
New data presented at Transcatheter Cardiovascular Therapeutics (TCT) 2023 from the TRILUMINATE pivotal trial confirm safety, effectiveness and improvements in quality of life when treating tricuspid regurgitation (a leaky valve) with TriClip, an investigational device in the US
October 26, 2023
Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves
October 26, 2023 — Abbott announced data from late-breaking presentations showing the impact of its minimally invasive…
Read More
New clinical data support use of lesion-specific FFRCT for diagnosis and treatment of patients with coronary artery disease
October 26, 2023
TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights
October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care…
Read More
October 26, 2023
Joint Statement on Aortic Valve Replacement in Low-Risk Patients Issued by Society of Thoracic Surgeons and European Association for Cardiothoracic Surgeons
October 26, 2023 — The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have…
Read More
October 25, 2023
New Study Reveals Inequities in Access to Mechanical Circulatory Support in US Patients with Cardiogenic Shock
October 26, 2023 — A new study presented at TCT 2023 revealed inequities in access to mechanical circulatory support in…
Read More
October 25, 2023
Six-Month Clinical Data from DESyne BDS Plus Randomized Controlled Trial (RCT) Presented at TCT 2023 Shines Spotlight on Safety, Effectiveness of World’s First Site-Specific Antithrombotic Drug Therapy
October 25, 2023 — Elixir Medical, developer of novel cardiovascular technologies, announced positive six-month…
Read More
TCT 2023: Medtronic adds to the body of evidence for Evolut TAVR with late-breaking clinical trial data from the Evolut Low Risk Trial
October 25, 2023
Medtronic Evolut TAVR Platform Outperforms Surgery with Sustained Valve Performance for Low-risk Patients at Four Years
October 25, 2023 — Medtronic plc, a global leader in healthcare technology, announced four-year results from the Evolut…
Read More
Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of all-cause mortality, disabling stroke and rehospitalization at five years
October 25, 2023
Five-year Data from Partner 3 Trial Demonstrate Excellent Survival for Patients Receiving Edwards Sapien 3 Valve
October 25, 2023 — Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates…
Read More
Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices
October 25, 2023
REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary Embolism
October 25, 2023 — Data from the REAL-PE study was presented today at Transcatheter Cardiovascular Therapeutics(TCT),…
Read More
Clinical research validates utility of IVL in complex nodular and eccentric calcium
October 25, 2023
New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies
October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational…
Read More
Clinical research validates utility of IVL in complex nodular and eccentric calcium
October 25, 2023
ConcertAI's TeraRecon Showcases New Clinical and AI Solutions Designed to Enhance Treatment Planning for Structural Heart Patients at TCT 2023
October 25, 2023 — ConcertAI's TeraRecon, a leader in advanced visualization and artificial intelligence (AI) for…
Read More
WATCH TAVR trial presented at the Transcatheter Cardiovascular Therapeutics annual conference
October 25, 2023
Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR
October 25, 2023 — Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now